Wilbur James
- SEC CIK
- 0001940931
No open-market purchases or sales filed in the past year.
Current role at each company
- TXG 10x Genomics, Inc.Chief Commercial Officeras of Nov 27, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Wilbur James as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 27, 2023 (view filing) | Nov 22 | 5 days | Wilbur JamesChief Commercial Officer | SSaleClass A Common Stock | −3.46K | $43.34 | −$150.1K | −4.0%83.3K after | |
| Nov 22, 2023 (view filing) | Nov 20 | 2 days | Wilbur JamesChief Commercial Officer | SSaleClass A Common Stock | −14.7K | $42.09 | −$619.5K | −14.5%86.8K after | |
| Aug 24, 2023 (view filing) | Aug 22 | 2 days | Wilbur JamesChief Commercial Officer | SSaleClass A Common Stock | −9.70K | $45.78 | −$444.0K | −8.7%101.3K after | |
| May 25, 2023 (view filing) | May 23 | 2 days | Wilbur JamesChief Commercial Officer | SSaleClass A Common Stock | −316 | $55.07 | −$17.4K | −0.3%111.0K after |